Celiac Science When Autoimmune Billions Flow, Celiac Families Should Pay Attention The Pharma Letter spotlights Forte Biosciences after argenx's $2.2B acquisition. Here's why this autoimmune drug story matters to celiac families. Aug 25, 2026 news autoimmune researchdermatitis herpetiformispharmaceutical news
